1 Coagulation Factor Concentrates Market Overview
1.1 Product Overview and Scope of Coagulation Factor Concentrates
1.2 Coagulation Factor Concentrates Segment by Type
1.2.1 Global Coagulation Factor Concentrates Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Factor VIII
1.2.3 Factor IX
1.2.4 Von Willebrand Factor
1.2.5 Prothrombin Complex Concentrates
1.2.6 Fibrinogen Concentrates
1.2.7 Factor XIII
1.3 Coagulation Factor Concentrates Segment by Application
1.3.1 Coagulation Factor Concentrates Sales Comparison by Application: (2021-2027)
1.3.2 Neurology
1.3.3 Immunology
1.3.4 Hematology
1.3.5 Critical Care
1.3.6 Pulmonology
1.3.7 Hemato-Oncology
1.3.8 Rheumatology
1.3.9 Others
1.4 Global Coagulation Factor Concentrates Market Size Estimates and Forecasts
1.4.1 Global Coagulation Factor Concentrates Revenue 2016-2027
1.4.2 Global Coagulation Factor Concentrates Sales 2016-2027
1.4.3 Coagulation Factor Concentrates Market Size by Region: 2016 Versus 2021 Versus 2027

2 Coagulation Factor Concentrates Market Competition by Manufacturers
2.1 Global Coagulation Factor Concentrates Sales Market Share by Manufacturers (2016-2021)
2.2 Global Coagulation Factor Concentrates Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Coagulation Factor Concentrates Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Coagulation Factor Concentrates Manufacturing Sites, Area Served, Product Type
2.5 Coagulation Factor Concentrates Market Competitive Situation and Trends
2.5.1 Coagulation Factor Concentrates Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Coagulation Factor Concentrates Players Market Share by Revenue
2.5.3 Global Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Coagulation Factor Concentrates Retrospective Market Scenario by Region
3.1 Global Coagulation Factor Concentrates Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Coagulation Factor Concentrates Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Coagulation Factor Concentrates Market Facts & Figures by Country
3.3.1 North America Coagulation Factor Concentrates Sales by Country
3.3.2 North America Coagulation Factor Concentrates Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Coagulation Factor Concentrates Market Facts & Figures by Country
3.4.1 Europe Coagulation Factor Concentrates Sales by Country
3.4.2 Europe Coagulation Factor Concentrates Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Region
3.5.1 Asia Pacific Coagulation Factor Concentrates Sales by Region
3.5.2 Asia Pacific Coagulation Factor Concentrates Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Coagulation Factor Concentrates Market Facts & Figures by Country
3.6.1 Latin America Coagulation Factor Concentrates Sales by Country
3.6.2 Latin America Coagulation Factor Concentrates Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Country
3.7.1 Middle East and Africa Coagulation Factor Concentrates Sales by Country
3.7.2 Middle East and Africa Coagulation Factor Concentrates Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Coagulation Factor Concentrates Historic Market Analysis by Type
4.1 Global Coagulation Factor Concentrates Sales Market Share by Type (2016-2021)
4.2 Global Coagulation Factor Concentrates Revenue Market Share by Type (2016-2021)
4.3 Global Coagulation Factor Concentrates Price by Type (2016-2021)

5 Global Coagulation Factor Concentrates Historic Market Analysis by Application
5.1 Global Coagulation Factor Concentrates Sales Market Share by Application (2016-2021)
5.2 Global Coagulation Factor Concentrates Revenue Market Share by Application (2016-2021)
5.3 Global Coagulation Factor Concentrates Price by Application (2016-2021)

6 Key Companies Profiled
6.1 CSL (Australia)
6.1.1 CSL (Australia) Corporation Information
6.1.2 CSL (Australia) Description and Business Overview
6.1.3 CSL (Australia) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL (Australia) Product Portfolio
6.1.5 CSL (Australia) Recent Developments/Updates
6.2 Grifols (Spain)
6.2.1 Grifols (Spain) Corporation Information
6.2.2 Grifols (Spain) Description and Business Overview
6.2.3 Grifols (Spain) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Grifols (Spain) Product Portfolio
6.2.5 Grifols (Spain) Recent Developments/Updates
6.3 Shire (Ireland)
6.3.1 Shire (Ireland) Corporation Information
6.3.2 Shire (Ireland) Description and Business Overview
6.3.3 Shire (Ireland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Shire (Ireland) Product Portfolio
6.3.5 Shire (Ireland) Recent Developments/Updates
6.4 Octapharma (Switzerland)
6.4.1 Octapharma (Switzerland) Corporation Information
6.4.2 Octapharma (Switzerland) Description and Business Overview
6.4.3 Octapharma (Switzerland) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Octapharma (Switzerland) Product Portfolio
6.4.5 Octapharma (Switzerland) Recent Developments/Updates
6.5 Kedrion (Italy)
6.5.1 Kedrion (Italy) Corporation Information
6.5.2 Kedrion (Italy) Description and Business Overview
6.5.3 Kedrion (Italy) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kedrion (Italy) Product Portfolio
6.5.5 Kedrion (Italy) Recent Developments/Updates
6.6 Bio Product Laboratory (UK)
6.6.1 Bio Product Laboratory (UK) Corporation Information
6.6.2 Bio Product Laboratory (UK) Description and Business Overview
6.6.3 Bio Product Laboratory (UK) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Bio Product Laboratory (UK) Product Portfolio
6.6.5 Bio Product Laboratory (UK) Recent Developments/Updates
6.7 Sanquin (Netherlands)
6.6.1 Sanquin (Netherlands) Corporation Information
6.6.2 Sanquin (Netherlands) Description and Business Overview
6.6.3 Sanquin (Netherlands) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanquin (Netherlands) Product Portfolio
6.7.5 Sanquin (Netherlands) Recent Developments/Updates
6.8 LFB (France)
6.8.1 LFB (France) Corporation Information
6.8.2 LFB (France) Description and Business Overview
6.8.3 LFB (France) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.8.4 LFB (France) Product Portfolio
6.8.5 LFB (France) Recent Developments/Updates
6.9 Biotest (Germany)
6.9.1 Biotest (Germany) Corporation Information
6.9.2 Biotest (Germany) Description and Business Overview
6.9.3 Biotest (Germany) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Biotest (Germany) Product Portfolio
6.9.5 Biotest (Germany) Recent Developments/Updates
6.10 Japan Blood Products Organization, China Biologic Products (China)
6.10.1 Japan Blood Products Organization, China Biologic Products (China) Corporation Information
6.10.2 Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
6.10.3 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Japan Blood Products Organization, China Biologic Products (China) Product Portfolio
6.10.5 Japan Blood Products Organization, China Biologic Products (China) Recent Developments/Updates
6.11 Green Cross Corporation (South Korea)
6.11.1 Green Cross Corporation (South Korea) Corporation Information
6.11.2 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Description and Business Overview
6.11.3 Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Green Cross Corporation (South Korea) Product Portfolio
6.11.5 Green Cross Corporation (South Korea) Recent Developments/Updates
6.12 Shanghai RAAS Blood Products (China)
6.12.1 Shanghai RAAS Blood Products (China) Corporation Information
6.12.2 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Description and Business Overview
6.12.3 Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Shanghai RAAS Blood Products (China) Product Portfolio
6.12.5 Shanghai RAAS Blood Products (China) Recent Developments/Updates

7 Coagulation Factor Concentrates Manufacturing Cost Analysis
7.1 Coagulation Factor Concentrates Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Coagulation Factor Concentrates
7.4 Coagulation Factor Concentrates Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Coagulation Factor Concentrates Distributors List
8.3 Coagulation Factor Concentrates Customers

9 Coagulation Factor Concentrates Market Dynamics
9.1 Coagulation Factor Concentrates Industry Trends
9.2 Coagulation Factor Concentrates Growth Drivers
9.3 Coagulation Factor Concentrates Market Challenges
9.4 Coagulation Factor Concentrates Market Restraints

10 Global Market Forecast
10.1 Coagulation Factor Concentrates Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Coagulation Factor Concentrates by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Coagulation Factor Concentrates by Type (2022-2027)
10.2 Coagulation Factor Concentrates Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Coagulation Factor Concentrates by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Coagulation Factor Concentrates by Application (2022-2027)
10.3 Coagulation Factor Concentrates Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Coagulation Factor Concentrates by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Coagulation Factor Concentrates by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

 

Research Methodology

 

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analysing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.